Gary K. Koski

Toll‐like receptor agonists as third signals for dendritic cell–tumor fusion vaccines

P. Cohen, S. Shu, G. Koski, 2010, Head & neck.

Reengineering dendritic cell‐based anti‐cancer vaccines

B. Czerniecki, Shuwen Xu, P. Cohen, 2008, Immunological reviews.

Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Interleukin-12 Synergize With Calcium Ionophore to Enhance Dendritic Cell Function

B. Czerniecki, I. Bedrosian, Shuwen Xu, 2000, Journal of immunotherapy.